As of 2025-09-19, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (6.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.22 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -648.2%.
The range of the Relative Valuation is (5.73) - (6.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 20.8x | 18.3x |
| Forward P/E multiples | 17.3x - 26.7x | 22.0x |
| Fair Price | (5.73) - (6.89) | (6.69) |
| Upside | -569.6% - -664.8% | -648.2% |
| Date | P/E |
| 2025-09-16 | -3.31 |
| 2025-09-15 | -3.37 |
| 2025-09-12 | -3.46 |
| 2025-09-11 | -3.34 |
| 2025-09-10 | -3.25 |
| 2025-09-09 | -3.40 |
| 2025-09-08 | -3.25 |
| 2025-09-05 | -3.28 |
| 2025-09-04 | -3.22 |
| 2025-09-03 | -3.25 |
| 2025-09-02 | -3.37 |
| 2025-08-29 | -3.31 |
| 2025-08-28 | -3.46 |
| 2025-08-27 | -3.40 |
| 2025-08-26 | -3.43 |
| 2025-08-25 | -3.40 |
| 2025-08-22 | -3.59 |
| 2025-08-21 | -3.52 |
| 2025-08-20 | -3.40 |
| 2025-08-19 | -3.49 |
| 2025-08-18 | -3.65 |
| 2025-08-15 | -3.74 |
| 2025-08-14 | -3.56 |
| 2025-08-13 | -3.34 |
| 2025-08-12 | -3.19 |
| 2025-08-11 | -3.13 |
| 2025-08-08 | -3.25 |
| 2025-08-07 | -3.37 |
| 2025-08-06 | -3.46 |
| 2025-08-05 | -3.16 |
| 2025-08-04 | -3.37 |
| 2025-08-01 | -3.22 |
| 2025-07-31 | -3.22 |
| 2025-07-30 | -3.07 |
| 2025-07-29 | -3.22 |
| 2025-07-28 | -3.28 |
| 2025-07-25 | -3.31 |
| 2025-07-24 | -3.40 |
| 2025-07-23 | -3.65 |
| 2025-07-22 | -3.62 |
| 2025-07-21 | -3.71 |
| 2025-07-18 | -3.71 |
| 2025-07-17 | -4.07 |
| 2025-07-16 | -3.89 |
| 2025-07-15 | -3.46 |
| 2025-07-14 | -3.56 |
| 2025-07-11 | -3.25 |
| 2025-07-10 | -3.40 |
| 2025-07-09 | -3.22 |
| 2025-07-08 | -2.76 |